-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, LK66eqQG/1wrMo3Bo5fdDuEVilBGpKY5HPYlgOgcKeLBsc6wpJoxGQYBV1Cf1YBT jtCiaHd1vEh9hojI0dIJEw== 0001209191-03-021650.txt : 20030915 0001209191-03-021650.hdr.sgml : 20030915 20030915181651 ACCESSION NUMBER: 0001209191-03-021650 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20030911 FILED AS OF DATE: 20030915 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: MURDOCK RICHARD D CENTRAL INDEX KEY: 0001221593 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-22890 FILM NUMBER: 03896470 MAIL ADDRESS: STREET 1: 6300 DUMBARTON CIRCLE CITY: FREMONT STATE: CA ZIP: 94555 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: SANGSTAT MEDICAL CORP CENTRAL INDEX KEY: 0000913610 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 943076069 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 6300 DUMBARTON CIRCLE CITY: FREMONT STATE: CA ZIP: 94555 BUSINESS PHONE: 5107894300 MAIL ADDRESS: STREET 1: 6300 DUMBARTON CIRCLE CITY: FREMONT STATE: CA ZIP: 94555 4 1 doc4.xml FORM 4 SUBMISSION X0201 42003-09-1110000913610SANGSTAT MEDICAL CORP SANG0001221593MURDOCK RICHARD DC/O SANGSTAT MEDICAL CORPORATION6300 DUMBARTON CIRCLEFREMONTCA945551100Chairman, President & CEOCommon Stock2003-09-114D0500022.5D0DCommon Stock2003-09-114M0900013.5A9000DCommon Stock2003-09-114D0900022.5D0DCommon Stock2003-09-114M01000019.75A10000DCommon Stock2003-09-114D01000022.5D0DCommon Stock2003-09-114M0400020.75A4000DCommon Stock2003-09-114D0400022.5D0DCommon Stock2003-09-114M0103422A1034DCommon Stock2003-09-114D0103422.5D0DCommon Stock2003-09-114M0187911.9375A1879DCommon Stock2003-09-114D0187922.5D 0DCommon Stock2003-09-114M01000010.9375A10000< directOrIndirectOwnership>DCommon Stock2003-09-114D01000022.5D0D< /ownershipNature>Common Stock2003-09-114M0800012.99A8000DCommon Stock2003-09-114D0800022.5D0DCommon Stock2003-09-11 4M01154617.32A11546DCommon Stock2003-09-11 4D01154622.5D0DCommon Stock2003-09-114M04845417.32A48454DCommon Stock2003-09-114D04845422.5D0DCommon Stock2003-09-114M0450448.88A45044DCommon Stock2003-09-114D04504422. 5D0DCommon Stock2003-09-114M02549568.88< value>A254956DCommon Stock2003-09-114D025495622.5D0DCommon Stock2003-09-114M0800021.58A8000DCommon Stock2003-09-114D0800022.5D0DOption to purchase Common Stock13.52003-09-112003-09-114M0900022.5D2003-09-112006-07-24Common Stock90000DOption to purchase Common Stock19.752003-09-112003-09-114M01000022.5D2003-09-112008-10-07Common Stock100000DOption to purchase Common Stock20.752003-09-112003-09-114M0400022.5D2003-09-112009-07-22Common Stock40000DOption to purchase Common Stock222003-09-112003-09-114M0103422.5D2003-09-112009-10-01Common Stock10340DOption to purchase Common Stock11.93752003-09-112003-09-114M0187922.5D2003-09-112011-01-02Common Stock18790DOption to purchase Common Stock10.93752003-09-112003-09-114M01000022.5D2003-09-112011-02-21Common Stock100000DOption to purchase Common Stock12.992003-09-112003-09-114M0800022.5D2003-09-112011-06-13Common Stock80000DOption to purchase Common Stock17.322003-09-112003-09-114M01154622.5D2003-09-112012-10-22Common Stock115460DOption to purchase Common Stock17.322003-09-112003-09-114M04845422.5D2003-09-112012-10-22Common Stock484540DOption to purchase Common Stock8.882003-09-112003-09-114M04504422.5D2003-09-11< /exerciseDate>2013-03-27Common Stock450440DOption to purchase Common Stock8.882003-09-112003-09-114M025495622.5D2003-09-112013-03-27Common Stock2549560DOption to purchase Common Stock21.582003-09-112003-09-114M0800022.5D2003-09-112012-05-14Common Stock80000DOption vesting was accelerated and the underlying common stock and all other common stock owned by the reporting person was acquired by Genzyme Corporation ("Genzyme") pursuant to the Agreement and Plan of Merger by and among Genzyme, Swift Starboard Corporation and SangStat Medical Corporation.See attached footnote page.Tamiko F. Lewis, Attorney-in-Fact for Richard Murdock2003-09-15 -----END PRIVACY-ENHANCED MESSAGE-----